UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Blood, ISSN 0006-4971, 04/2015, Volume 125, Issue 18, pp. 2738 - 2739
Life Sciences & Biomedicine | Hematology | Science & Technology | Leukemia, Myeloid, Acute - drug therapy | Drug Resistance, Neoplasm - genetics | Leukemia, Myeloid, Acute - diagnosis | Phosphoric Monoester Hydrolases - physiology | Humans | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Frontiers in oncology, ISSN 2234-943X, 02/2021, Volume 11
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 986 - 996
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Confidence Intervals | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Dose-Response Relationship, Drug | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Remission Induction - methods | Odds Ratio | Daunorubicin - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Risk Assessment | Survival Rate | Treatment Outcome | Randomized Controlled Trials as Topic | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Leukemia, Myeloid, Acute - diagnosis | Infusions, Intravenous | Aminoglycosides - therapeutic use | Chemotherapy | Adults | Analysis | Cancer | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 3, pp. 291 - 299
Life Sciences & Biomedicine | Hematology | Science & Technology | Blast Crisis - drug therapy | Blast Crisis - pathology | Prognosis | Prospective Studies | Follow-Up Studies | Leukemia, Myeloid, Acute - pathology | Humans | Male | Survival Rate | Leukemia, Myeloid, Acute - mortality | Antimetabolites, Antineoplastic - therapeutic use | International Agencies | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Female | Aged | Neoplasm Staging | Azacitidine - therapeutic use | Index Medicus | Abridged Index Medicus | Plenary Paper
Journal Article
EJHaem, ISSN 2688-6146, 02/2021, Volume 2, Issue 1, pp. 25 - 25
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 384 - 395
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Leukemia, Myeloid, Acute - pathology | Humans | Hematopoietic Stem Cells - pathology | Immunophenotyping | Male | Transplantation, Heterologous | DNA Primers - genetics | Mice, SCID | Interleukin Receptor Common gamma Subunit - genetics | Neoplastic Stem Cells - transplantation | Mice, Knockout | Interleukin Receptor Common gamma Subunit - deficiency | Cell Lineage | Animals | Models, Biological | Base Sequence | Neoplastic Stem Cells - pathology | Female | Mice, Inbred NOD | Cell Differentiation | Mice | Leukemia, Myeloid, Acute - physiopathology | Neoplastic Stem Cells - physiology | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 04/2020, Volume 189, Issue 1, pp. 7 - 7
Journal Article
Haematologica (Roma), ISSN 0390-6078, 11/2018, Volume 103, Issue 12, pp. 2040 - 2048
Journal Article
Blood, ISSN 0006-4971, 03/2014, Volume 123, Issue 13, pp. 1986 - 1986
Life Sciences & Biomedicine | Hematology | Science & Technology | Leukocytes - pathology | Recurrence | Diagnosis, Differential | Lymphohistiocytosis, Hemophagocytic - pathology | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Female | Leukemic Infiltration - pathology | Phagocytosis | Index Medicus | Abridged Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 12/2017, Volume 17, Issue 1, pp. 852 - 852
AML | Low-dose cytarabine | Response | Induction chemotherapy | Myelodysplasia-related changes | Azacitidine | Acute myeloid leukaemia | Survival | AML-MRC | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Age Factors | Cytarabine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Treatment Outcome | Leukemia, Myeloid, Acute - etiology | Myelodysplastic Syndromes - complications | Leukemia, Myeloid, Acute - mortality | Antimetabolites, Antineoplastic - therapeutic use | Myelodysplastic Syndromes - mortality | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Female | Aged | Myelodysplastic Syndromes - drug therapy | Azacitidine - therapeutic use | Chemotherapy | Usage | Dosage and administration | Cytarabine | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 24, pp. 3322 - 3327
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Azacitidine - adverse effects | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Antimetabolites, Antineoplastic - therapeutic use | Treatment Failure | Antimetabolites, Antineoplastic - adverse effects | Myelodysplastic Syndromes - mortality | Female | Aged | Myelodysplastic Syndromes - drug therapy | Azacitidine - therapeutic use | Cohort Studies | Index Medicus | ORIGINAL REPORTS | Hema5 | Hema6
Journal Article
Blood, ISSN 0006-4971, 07/2016, Volume 128, Issue 2, pp. 253 - 264
Life Sciences & Biomedicine | Hematology | Science & Technology | Neoplasm Transplantation | Leukemia, Myeloid, Acute - pathology | Stromal Cells - pathology | Coculture Techniques | Humans | Leukemia, Myeloid, Acute - metabolism | Stromal Cells - metabolism | Bone Marrow Cells - pathology | Mitochondria - metabolism | Mitochondria - pathology | Animals | Heterografts | Mice, Nude | U937 Cells | HL-60 Cells | Mice | Bone Marrow Cells - metabolism | Index Medicus | Abridged Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 09/2019, Volume 19, Issue 1, pp. 883 - 883
French European deprivation index | Observational study | Cancer management and survival | Acute myeloid leukemia | Elderly patients | Life Sciences & Biomedicine | Oncology | Science & Technology | Cancer Survivors | Prognosis | Prospective Studies | Age Factors | Follow-Up Studies | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Socioeconomic Factors | Leukemia, Myeloid, Acute - mortality | Patient Acceptance of Health Care | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Healthcare Disparities | Leukemia, Myeloid, Acute - drug therapy | Female | Aged | France | Longitudinal Studies | Index Medicus | Life Sciences | Santé publique et épidémiologie | Cancer
Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 5, pp. 822 - 829
Mutations of key transcription factor in myeloid malignancies | Life Sciences & Biomedicine | Hematology | Science & Technology | Neutropenia - metabolism | Humans | Leukemia, Myeloid, Acute - metabolism | Genetic Diseases, Inborn - genetics | Child, Preschool | Male | Genetic Diseases, Inborn - pathology | Genetic Diseases, Inborn - therapy | Genetic Loci | Mutation, Missense | Myelodysplastic Syndromes - therapy | Cell Transformation, Neoplastic - genetics | Adult | Female | Registries | Genetic Diseases, Inborn - metabolism | France | Neutropenia - genetics | Child | GATA2 Transcription Factor - genetics | Leukemia, Myeloid, Acute - therapy | Myelodysplastic Syndromes - metabolism | Leukemia, Myeloid, Acute - pathology | Cell Transformation, Neoplastic - metabolism | Pedigree | Adolescent | GATA2 Transcription Factor - metabolism | Myelodysplastic Syndromes - genetics | Cell Transformation, Neoplastic - pathology | Myelodysplastic Syndromes - pathology | Amino Acid Substitution | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus | Phagocytes, Granulocytes, and Myelopoiesis | Pediatric Hematology | Myeloid Neoplasia
Journal Article